Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Dec;30(3):847–850. doi: 10.1128/iai.30.3.847-850.1980

Ontogeny of murine cellular cytotoxicity to herpes simplex virus-infected cells.

S Kohl, L S Loo
PMCID: PMC551392  PMID: 6262242

Abstract

Mice infected with herpes simplex virus either orally or intraperitoneally had a markedly age-related mortality. All animals under 3 weeks of age died, whereas all those over 3 weeks of age survived. The ability of murine peritoneal cells to kill herpes simplex virus-infected target cells in the absence (natural killer cytotoxicity) or presence (antibody-dependent cellular cytotoxicity) of antiviral antibody was similarly correlated with age and survival. This correlation is further support for the relevance of these antiviral defense mechanisms, and it may help explain the profound susceptibility of neonatal mice to herpes simplex virus infection.

Full text

PDF
847

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ching C., Lopez C. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody. Infect Immun. 1979 Oct;26(1):49–56. doi: 10.1128/iai.26.1.49-56.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Davis W. B., Taylor J. A., Oakes J. E. Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody. J Infect Dis. 1979 Oct;140(4):534–540. doi: 10.1093/infdis/140.4.534. [DOI] [PubMed] [Google Scholar]
  3. Hayashi K., Kurata T., Morishima T., Nassery T. Analysis of the inhibitory effect of peritoneal macrophages on the spread of herpes simplex virus. Infect Immun. 1980 May;28(2):350–358. doi: 10.1128/iai.28.2.350-358.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hirsch M. S., Zisman B., Allison A. C. Macrophages and age-dependent resistance to Herpes simplex virus in mice. J Immunol. 1970 May;104(5):1160–1165. [PubMed] [Google Scholar]
  5. JOHNSON R. T. THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGE. J Exp Med. 1964 Sep 1;120:359–374. doi: 10.1084/jem.120.3.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. KILBOURNE E. D., HORSFALL F. L., Jr Studies of herpes simplex virus in newborn mice. J Immunol. 1951 Oct;67(4):321–329. [PubMed] [Google Scholar]
  7. Kohl S., Cahall D. L., Walters D. L., Schaffner V. E. Murine antibody-dependent cellular cytotoxicity to herpes simplex virus-infected target cells. J Immunol. 1979 Jul;123(1):25–30. [PubMed] [Google Scholar]
  8. Kohl S., Shaban S. S., Starr S. E., Wood P. A., Nahmias A. J. Human neonatal and maternal monocyte-macrophage and lymphocyte-mediated antibody-dependent cytotoxicity to cells infected with herpes simplex. J Pediatr. 1978 Aug;93(2):206–210. doi: 10.1016/s0022-3476(78)80497-1. [DOI] [PubMed] [Google Scholar]
  9. Mintz L., Drew W. L., Hoo R., Finley T. N. Age-dependent resistance of human alveolar macrophages to herpes simplex virus. Infect Immun. 1980 May;28(2):417–420. doi: 10.1128/iai.28.2.417-420.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mogensen S. C. Macrophages and age-dependent resistance to hepatitis induced by herpes simplex virus type 2 im mice. Infect Immun. 1978 Jan;19(1):46–50. doi: 10.1128/iai.19.1.46-50.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nahmias A. J., Alford C. A., Korones S. B. Infection of the newborn with herpesvirus hominis. Adv Pediatr. 1970;17:185–226. [PubMed] [Google Scholar]
  12. Oakes J. E., Rosemond-Hornbeak H. Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection. Infect Immun. 1978 Aug;21(2):489–495. doi: 10.1128/iai.21.2.489-495.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Piontek G. E., Weltzin R., Tompkins W. A. Enhanced cytotoxicity of mouse natural killer cells for vaccinia and herpes virus-infected targets. J Reticuloendothel Soc. 1980 Feb;27(2):175–188. [PubMed] [Google Scholar]
  14. Rager-Zisman B., Allison A. C. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J Immunol. 1976 Jan;116(1):35–40. [PubMed] [Google Scholar]
  15. Rager-Zisman B., Bloom B. R. Immunological destruction of herpes simplex virus I infected cells. Nature. 1974 Oct 11;251(5475):542–543. doi: 10.1038/251542a0. [DOI] [PubMed] [Google Scholar]
  16. Ramshaw I. A. Lysis of herpesvirus-infected cells by immune spleen cells. Infect Immun. 1975 Apr;11(4):767–769. doi: 10.1128/iai.11.4.767-769.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Shore S. L., Milgrom H., Wood P. A., Nahmias A. J. Antibody-dependent cellular cytotoxicity to target cells infected with herpes simplex viruses: functional adequacy in the neonate. Pediatrics. 1977 Jan;59(1):22–28. [PubMed] [Google Scholar]
  18. Starr S. E., Visintine A. M., Tomeh M. O., Nahmias A. J. Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection. Proc Soc Exp Biol Med. 1976 May;152(1):57–60. doi: 10.3181/00379727-152-39327. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES